The letter highlights HHS’s May 28, 2025, cancellation of a $766 million contract with Moderna for developing vaccines against future pandemic influenza strains, including bird flu.

In experiments conducted in a biosafety level 3 facility, the researchers studied ferrets that had antibodies to seasonal flu ...

US Health Secretary Robert F. Kennedy Jr.’s vaccine policies and commentary largely appear to contradict his pledge to revamp ...

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

A study spearheaded by researchers at Stanford Medicine reports a substantial increase in cases of acute necrotizing ...

HPAI is more than an animal health crisis: it is a global emergency destabilizing agriculture, food security, trade and ...

Bacteriologist and parasitologist Michelle Jakaitis uses a microscope to view a training sample of veligers, which are the ...

Studies suggest that people who had seasonal flus or vaccinations have low antibody levels against H5N1 bird flu.

The HHS is betting $500 million on developing a universal flu vaccine that could protect against multiple flu strains.

Novavax, Inc. (NVAX) on Thursday announced preclinical data demonstrating that the company’s H5N1 bird flu vaccine candidate ...

Cambodia's health ministry today announced another H5N1 avian flu infection, the country's 14th of the year. Meanwhile, ...

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...